Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

NCT02620774 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.

NCT NCT02620774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
Lead sponsor
Hartford Hospital
Phase
Phase 1
Overall status
Completed
Start date
February 19, 2016
Completion date
April 30, 2017
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, healthy volunteers, wound infection